Fund profile

Compound

New York, United States

Leading

About

Compound is a thesis-driven, research-centric investment firm that focuses on early-stage investments across deeply technical and science-driven areas. The firm is dedicated to accelerating the futures envisioned by its founders, helping them solve complex technical problems, communicate breakthroughs, and scale commercialization efforts. Founded by Michael Dempsey, Compound has a diverse team of investors, researchers, and operators with extensive domain expertise. Notable team members include General Partner David Hirsch and Venture Partners like Celeste Holz-Schietinger, who has a background in biology and was instrumental in creating plant-based meat products at Impossible Foods. Compound's portfolio is broad, encompassing sectors like AI/ML, robotics, healthcare, biology, and crypto. Notable investments include companies such as Deepgram, Hyphen, Arbitrum, and Dapper Labs. The firm emphasizes a hands-on approach and leverages its network and prior experiences to support the growth and success of its portfolio companies.

Details

Highlights

$503.7k

Historical average check

$50M

Historical max check

October 2024

Last investment date

226

Investments

Energy & Utilities

AI & Deep Tech

Software & Apps

Healthtech & Wellness

Biotech

Pharma

Sports & Fitness

Transportation & Mobility

Other

Funds that also invest in AI & Deep Tech